| 3.74 0.203 (5.74%) | 12-26 16:00 | |||||||||||||
|
|
| Short term | ||||
| Mid term | ||||
| Targets | 6-month : | 4.62 | 1-year : | 5.2 |
| Resists | First : | 3.95 | Second : | 4.46 |
| Pivot price | 3.75 |
|||
| Supports | First : | 3.15 | Second : | 2.62 |
| MAs | MA(5) : | 3.62 |
MA(20) : | 3.73 |
| MA(100) : | 3.78 |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | 0 |
| %K %D | K(14,3) : | 20.6 |
D(3) : | 22.7 |
| RSI | RSI(14): 51.9 |
|||
| 52-week | High : | 7.36 | Low : | 1.71 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ SINT ] has closed above bottom band by 48.5%. Bollinger Bands are 17.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.74 - 3.76 | 3.76 - 3.78 |
| Low: | 3.45 - 3.47 | 3.47 - 3.49 |
| Close: | 3.71 - 3.74 | 3.74 - 3.77 |
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
Mon, 08 Dec 2025
SINTX Technologies to Participate in Sidoti & Company Investor Conference - Yahoo Finance
Mon, 08 Dec 2025
Ascendiant Capital Maintains Sintx Technologies (SINT) Buy Recommendation - Nasdaq
Mon, 01 Dec 2025
Sintx Technologies, Inc. Signs Supply Agreement with Evonik Corporation - TradingView — Track All Markets
Tue, 21 Oct 2025
Insider Buying: Eric Olson Acquires Additional Shares of SINTX T - GuruFocus
Thu, 16 Oct 2025
$30B Antipathogenic Market: SINTX USPTO Notice of Allowance for Method Patent Broadens Licensing - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 2.99e+006 (%) |
| Held by Institutions | 17 (%) |
| Shares Short | 254 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -9.26e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 601.9 % |
| Return on Equity (ttm) | -53.1 % |
| Qtrly Rev. Growth | 1.27e+006 % |
| Gross Profit (p.s.) | -117.47 |
| Sales Per Share | -323.88 |
| EBITDA (p.s.) | 1.04921e+006 |
| Qtrly Earnings Growth | -3.8 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -7 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.02 |
| Price to Cash Flow | 2.1 |
| Dividend | 0 |
| Forward Dividend | 223230 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |